Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
mardi, novembre 17
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Advanced Biomed Inc
ADVB
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$2.15
-0.07
-3.15%
Dern. MÀJ: Nov 17, 9:58 AM
Get Report
Aperçu
Actualités
Graphiques
Prévisions de résultats
Données financières
Sentiment
Comparer
Rapport sur les stocks
Résultats:
Les résultats Q1 2027 ont été publiés le jeu. nov. 12th, après la fermeture du marché
Advanced Biomed Financials
Advanced Biomed (ADVB) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Advanced Biomed Q3 EPS $(0.38) Up From $(1.17) YoY
Advanced Biomed (NASDAQ:ADVB) reported quarterly losses of $(0.38) per share. This is a 67.52 percent increase over losses of $(1.17) per share from the same period last year.
Benzinga Newsdesk
PRO
Advanced Biomed Q2 EPS $0.32
Advanced Biomed (NASDAQ:ADVB) reported quarterly earnings of $0.32 per share.
Benzinga Newsdesk
PRO
Advanced Biomed Q1 EPS $(0.02) Down From $(0.01) YoY
Advanced Biomed (NASDAQ:ADVB) reported quarterly losses of $(0.02) per share. This is a 100 percent decrease over losses of $(0.01) per share from the same period last year.
Benzinga Newsdesk
PRO
Advanced Biomed Q4 EPS $(0.03) Up From $(0.04) YoY
Advanced Biomed (NASDAQ:ADVB) reported quarterly losses of $(0.03) per share. This is a 25 percent increase over losses of $(0.04) per share from the same period last year.
Benzinga Newsdesk